Related Experiment Video
Updated: Aug 6, 2026

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor
Published on: August 18, 2023
The competitive acquisition program for drugs and biologicals
1Leaders in Medicine Inc., Wayne, Il, USA.
Abstract:
Unlike the Medicare Part D program, which has a significant number of participating plans, the new Competitive Acquisition Program (CAP), which was to have started on Jan. 1, 2006, along with Medicare Part D, did not because, in part, of a lack of interest. As a result, the program was delayed until July 1, 2006. This new program separates the physician from the purchase and billing of medications provided in the physician's office. Under CAP, physicians sign with a specialty pharmacy provider that will deliver the medications to the physicians as ordered and then bill Medicare directly. This will alleviate some physician administrative responsibilities. Although it is unlikely that high-volume Medicare Part B medication providers, such as oncologists, will use a CAP provider, it is likely that busy primary care physicians and other specialists not usually involved in providing medications in their offices now may start to take advantage of this valuable service.
Related Concept Videos
Drug Products: Biologics, Biosimilars and Interchangeables
Biopharmaceutics and Pharmacokinetics: Overview
Drug Nomenclature
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Bioequivalence studies: Biowaivers
Bioequivalence: Overview

